CSI Market
Sign In | Register

Haemonetics (HAE) Annual Income Statement

Annual · GAAP · USD millions
Access HAE quarterly income statements →
Reviewing income statement figures over time helps illustrate how Haemonetics generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 28 2026)
2026 		(Mar 29 2025) (Mar 30 2024) (Apr 01 2023) (Apr 02 2022)
Revenues
Revenue From Contract With Customer Including Assessed Tax1,334.03
Total Revenue1,333.59
Costs & Expenses
Cost of Goods and Services Sold546.00
Gross Profit787.59
Selling, Administration, Marketing442.42
Research and Development Expense59.77
Impairment of Intangible Assets, Finite-lived86.55
Other Operating Expense / -Income0.00
Total operating costs including COS1,176.85
Operating income / -loss156.73
Net Interest Expense / -Income0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Other loss / -income28.70
Total costs & expenses1,205.56
Income & Taxes
Income / -loss before income taxes128.03
Income taxes expenses / -benefit30.72
Income after income taxes97.31
Net income / -loss of other equity0.00
Income / -loss from continuing operations97.31
Net income / -loss97.31
Income / -loss to shareholder97.31
EBIT128.03
EBITD174.41
EBITDA186.21
Earnings Per Share
Basic EPS (excl. extra items)2.06
Basic Net EPS2.06
Basic shares outstanding (Mill. of Units)47.18
Diluted Net EPS2.05
Diluted average shares (Mill. of Units)47.35
4 historic quarters locked

Sign in to unlock the full Haemonetics income statement history.

Sign In Create Free Account

About Haemonetics Corp Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: May 20, 2026
  • Original filing: hae-20260328.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.